IL308827A - Systems and methods for monoclonal antibody nomography - Google Patents
Systems and methods for monoclonal antibody nomographyInfo
- Publication number
- IL308827A IL308827A IL308827A IL30882723A IL308827A IL 308827 A IL308827 A IL 308827A IL 308827 A IL308827 A IL 308827A IL 30882723 A IL30882723 A IL 30882723A IL 308827 A IL308827 A IL 308827A
- Authority
- IL
- Israel
- Prior art keywords
- nomograms
- systems
- methods
- monoclonal antibody
- monoclonal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Computing Systems (AREA)
- Bioinformatics & Computational Biology (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioethics (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163194987P | 2021-05-29 | 2021-05-29 | |
| PCT/US2022/031650 WO2022256346A1 (en) | 2021-05-29 | 2022-05-31 | Systems and methods for monoclonal antibody nomograms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308827A true IL308827A (en) | 2024-01-01 |
Family
ID=82258506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308827A IL308827A (en) | 2021-05-29 | 2022-05-31 | Systems and methods for monoclonal antibody nomography |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220383991A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4348662A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527230A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240015088A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022286921A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3221920A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308827A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022256346A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12239690B1 (en) * | 2024-06-05 | 2025-03-04 | Well Cell Global Llc | Method and system for tuning hormone receptors through the dynamic intravenous delivery of a hormone according to a target physiological cadence |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014055978A1 (en) | 2012-10-05 | 2014-04-10 | Baysient LLC | System and method for providing patient-specific dosing as a function of mathematical models |
| US11501863B2 (en) | 2015-04-09 | 2022-11-15 | Diane R. MOULD | Systems and methods for patient-specific dosing |
| KR20250153867A (ko) | 2018-04-23 | 2025-10-27 | 다이앤 몰드 | 적응성 투여 요법의 수정 시스템 및 방법 |
| US20200321096A1 (en) | 2019-03-08 | 2020-10-08 | Diane R. MOULD | Systems and methods for drug-agnostic patient-specific dosing regimens |
-
2022
- 2022-05-31 WO PCT/US2022/031650 patent/WO2022256346A1/en not_active Ceased
- 2022-05-31 KR KR1020237044179A patent/KR20240015088A/ko active Pending
- 2022-05-31 JP JP2023573361A patent/JP2024527230A/ja active Pending
- 2022-05-31 CA CA3221920A patent/CA3221920A1/en active Pending
- 2022-05-31 AU AU2022286921A patent/AU2022286921A1/en active Pending
- 2022-05-31 IL IL308827A patent/IL308827A/en unknown
- 2022-05-31 US US17/829,075 patent/US20220383991A1/en active Pending
- 2022-05-31 EP EP22734431.4A patent/EP4348662A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220383991A1 (en) | 2022-12-01 |
| KR20240015088A (ko) | 2024-02-02 |
| JP2024527230A (ja) | 2024-07-24 |
| EP4348662A1 (en) | 2024-04-10 |
| AU2022286921A1 (en) | 2024-01-18 |
| WO2022256346A1 (en) | 2022-12-08 |
| CA3221920A1 (en) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287025A (en) | Systems and methods to classify antibodies | |
| EP3901175A4 (en) | ANTI-CD73 MONOCLONAL ANTIBODY AND USE THEREOF | |
| EP4010378A4 (en) | ANTICCR8 MONOCLONAL ANTIBODIES AND USES THEREOF | |
| ZA202004494B (en) | Anti-tmprss2 antibodies and antigen-binding fragments | |
| EP3833976A4 (en) | SYSTEMS AND METHODS FOR THE SIMULTANEOUS DETECTION OF ANTIGENS AND ANTIGEN-SPECIFIC ANTIBODIES | |
| EP3459973A4 (en) | Anti-human pd-l1 humanized monoclonal antibody and application thereof | |
| PT4082570T (pt) | Anticorpo anti-ctla-4 e a sua utilização | |
| ZA202003858B (en) | Monoclonal antibodies and methods for using same | |
| EP3901172A4 (en) | HUMANIZED ANTI-PD-1 ANTIBODIES AND THEIR USE | |
| EP3176182A4 (en) | Anti-pd-1 monoclonal antibody and obtaining method therefor | |
| EP3466974A4 (en) | HUMANIZED MONOCLONAL ANTI-HUMAN PD-1 ANTIBODY AND USE THEREOF | |
| SG11202012148RA (en) | Monoclonal antibodies against human tim-3 | |
| AU2021462438B2 (en) | Anti-human interleukin-33 monoclonal antibody and use thereof | |
| SMT202600020T1 (it) | Anticorpi monoclonali anti-gprc5d e usi di essi | |
| EP3778635A4 (en) | ANTI-PD-L1 ANTIBODIES AND ITS USE | |
| HRP20260007T1 (hr) | Humanizirano antitijelo protiv il17a i njegova uporaba | |
| PL3932949T3 (pl) | Przeciwciało anty-cd25 i jego zastosowanie | |
| IL285569A (en) | Anti-pd-l1 antibody and use thereof | |
| EP4082572A4 (en) | ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD AND ITS APPLICATION | |
| IL291049A (en) | Anti-cd47 monoclonal antibody and use thereof | |
| EP3733699A4 (en) | FULLY HUMANIZED MONOCLONAL NEUTRALIZING ANTIBODY FOR TETANUS TOXIN AND ITS USE | |
| IL304807A (en) | Anti-pd-1 antibodies and their use | |
| EP3901171A4 (en) | HUMAN ANTI-TIM-3 MONOCLONAL ANTIBODY AND USE THEREOF | |
| IL317849A (en) | Anti-SLC34A2 monoclonal antibodies and their uses | |
| GB201911211D0 (en) | Monoclonal antibodies against ambra-1 |